| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11033-018-4168-X |
| P698 | PubMed publication ID | 29569103 |
| P50 | author | Ameer Hamza | Q88141970 |
| P2093 | author name string | Uqba Khan | |
| Sidrah Khawar | |||
| Daniel Snower | |||
| P2860 | cites work | A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells | Q33922842 |
| A novel syndrome of radiation-associated acute myeloid leukemia involving AML1 gene translocations. | Q34509142 | ||
| Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99. | Q34579668 | ||
| Prdm16 is a physiologic regulator of hematopoietic stem cells. | Q35029415 | ||
| Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature | Q36360682 | ||
| High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML. | Q38301831 | ||
| High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial | Q41036515 | ||
| NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia | Q44123939 | ||
| Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis | Q44292097 | ||
| 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop | Q46139148 | ||
| Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemia | Q48121119 | ||
| Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. | Q51761197 | ||
| Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML. | Q55041790 | ||
| NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. | Q55057111 | ||
| CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy | Q77381093 | ||
| Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22) | Q80369116 | ||
| P433 | issue | 3 | |
| P921 | main subject | acute myeloid leukemia | Q264118 |
| P304 | page(s) | 347-351 | |
| P577 | publication date | 2018-03-22 | |
| P1433 | published in | Molecular Biology Reports | Q15752755 |
| P1476 | title | Acute myeloid leukemia with translocation (1;21) | |
| P478 | volume | 45 |
Search more.